RE:RE:RE:Inflection Point@Lastofthefranks & Adventurous: It's great to hear from you and to see such thoughtful posts. I agree that we are at an inflection point, since NL is currently providing low cost, high quality, and well branded product to consumers and BC will serve as a jumping-off point for sales across Canada. These sales in BC will help bolster the brand in preparation for expansion into other provinces this year. As mentioned by NL, these sales will start to show in the Q4 financials...NL did well to anticipate the importance of a sales license. While they will still continue B2B sales, they no longer have to rely on B2B to make monthly sales less chunky. I also think that it was wise to have Sherry Boodram on the team, since she worked with Health Canada's Medical Cannabis Program and knows the ins and outs of applications and compliance. She's clearly served them well. Getting the human trials license was also good foresight from NL, and seems to have proved invaluable, since the experience of each online poster I've seen who tried NL's oils, has been very good. This excitement over NL's product and value is a taste of things to come, and a definite inflection point (whether or not the share price immediately reflects this or not). In my opinion, with low cost, high quality, good branding, and low overhead, it is only a matter of time before shareholders (including the NL team which is heavily invested) will be rewarded. I am very excited for the future.